BackHomology Medicines Overview

Homology Medicines EBIT

EBIT (Earnings Before Interest and Taxes) analysis for FIXX.

Quarterly EBIT

-$7.72M
36.85% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

$21.29M
133.84% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)